Cargando…
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
In the past twenty years, 14 new antiepileptic drugs have been approved for use in the United States and/or Europe. These drugs are eslicarbazepine acetate, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topiramate, vigab...
Autor principal: | Krasowski, Matthew D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904466/ https://www.ncbi.nlm.nih.gov/pubmed/20640233 http://dx.doi.org/10.3390/ph3061908 |
Ejemplares similares
-
Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’
por: Öztiryaki, Ahmet H., et al.
Publicado: (2010) -
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs)
por: Sommerfeld-Klatta, Karina, et al.
Publicado: (2020) -
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
Diabetic nephropathy: newer therapeutic perspectives
por: Keri, Krishna C., et al.
Publicado: (2018) -
Effectiveness, tolerability and practical application of the newer generation anti-obesity medications
por: MacDaniels, Jeffrey S., et al.
Publicado: (2016)